Summit Therapeutics Inc (SMMT)

Nov 04, 2024

SMMT Surges as Analyst Initiates Coverage with Buy Rating - GuruFocus.com

Nov 04, 2024

Nov 04, 2024

Why Summit Therapeutics Stock Was a Winner Today - Yahoo Finance

Nov 04, 2024

Nov 04, 2024

Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer? - MSN

Nov 04, 2024

Nov 04, 2024

Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo - Yahoo Finance UK

Nov 04, 2024

Nov 04, 2024

Summit Therapeutics Leads the Parade of Big Gainers - Yahoo Finance

Nov 04, 2024

Nov 04, 2024

Summit Therapeutics Leads The Parade Of Big Gainers - Forbes

Nov 04, 2024

Nov 04, 2024

Summit Therapeutics (NASDAQ:SMMT) Earns Market Outperform Rating from Analysts at JMP Securities - MarketBeat

Nov 04, 2024

Nov 03, 2024

3 Magnificent Stocks Under $100 to Buy in November - The Motley Fool

Nov 03, 2024

Nov 01, 2024

abrdn plc Invests $24.89 Million in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Nov 01, 2024

Oct 31, 2024

H.C. Wainwright cuts Summit Therapeutics stock target, maintains Buy amid study expansion - Investing.com Canada

Oct 31, 2024

Oct 31, 2024

Summit Therapeutics Inc (SMMT) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Insights - GuruFocus.com

Oct 31, 2024

Oct 31, 2024

Summit Therapeutics (NASDAQ:SMMT) Price Target Cut to $44.00 by Analysts at HC Wainwright - MarketBeat

Oct 31, 2024

Oct 31, 2024

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024

Oct 31, 2024

Summit Therapeutics Posts Wider-Than-Expected Loss in Q3, Nil Sales - Yahoo Finance

Oct 31, 2024

Oct 31, 2024

Is Summit Therapeutics a Millionaire Maker? - MSN

Oct 31, 2024

Oct 31, 2024

Summit Therapeutics Inc (SMMT) Q3 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance

Oct 31, 2024

Oct 31, 2024

Summit Therapeutics reports Q3 EPS (5c), consensus (7c) - MSN

Oct 31, 2024

Oct 31, 2024

Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insigh - GuruFocus.com

Oct 31, 2024

Oct 31, 2024

Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insight - Yahoo Finance

Oct 31, 2024

Oct 31, 2024

Summit Therapeutics Advances NSCLC Trials and Strengthens Financials - TipRanks

Oct 31, 2024

Oct 30, 2024

Summit Therapeutics (NASDAQ:SMMT) Stock Price Down 10.4%What's Next? - MarketBeat

Oct 30, 2024

Oct 30, 2024

Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024 - BioSpace

Oct 30, 2024

Oct 30, 2024

Summit Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 30, 2024

Oct 29, 2024

China Universal Asset Management Co. Ltd. Purchases 56,879 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Oct 29, 2024

Oct 28, 2024

Tesla, Xpeng, Summit Therapeutics lead Monday's morning market cap stock movers - Investing.com Australia

Oct 28, 2024

Oct 28, 2024

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update - StockTitan

Oct 28, 2024

Oct 27, 2024

Summit Therapeutics Inc. (SMMT): An Unstoppable Stock That Could Make You Richer - Insider Monkey

Oct 27, 2024

Oct 27, 2024

Billionaire Buys Miami Penthouse After His Firm’s 689% Stock Rally - MSN

Oct 27, 2024

Oct 27, 2024

8 Unstoppable Stocks That Could Make You Richer - Insider Monkey

Oct 27, 2024

Oct 26, 2024

(SMMT) Trading Report - Stock Traders Daily

Oct 26, 2024

Oct 25, 2024

Summit Therapeutics Stock: Sell or Hold Before Q3 Earnings? - MSN

Oct 25, 2024

Oct 24, 2024

Summit Therapeutics (SMMT) to Release Earnings on Wednesday - MarketBeat

Oct 24, 2024

Oct 24, 2024

Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising? - AOL

Oct 24, 2024

Oct 23, 2024

Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024 - Business Wire

Oct 23, 2024

Oct 23, 2024

Summit Stock Skyrockets Nearly 700% YTD: Time to Sell or Hold? - Zacks Investment Research

Oct 23, 2024

Oct 23, 2024

Exchange Traded Concepts LLC Trims Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Oct 23, 2024

Oct 22, 2024

Summit Therapeutics (NASDAQ:SMMT) Trading 0.4% HigherStill a Buy? - MarketBeat

Oct 22, 2024

Oct 22, 2024

PD-1 Non-Small Cell Lung Cancer Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Summit Therapeutics, Arcus Biosciences,GSK, Pfizer - The Globe and Mail

Oct 22, 2024

Oct 22, 2024

Billionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You? - AOL

Oct 22, 2024

Oct 21, 2024

Summit Therapeutics (NASDAQ:SMMT) Trading 0.8% HigherTime to Buy? - MarketBeat

Oct 21, 2024

Oct 21, 2024

SUMMIT THERAPEUTICS: CAN LIGHTNING STRIKE TWICE? - Sick Economics

Oct 21, 2024

Oct 20, 2024

Is Summit Therapeutics Inc. (SMMT) the Best QQQ Stock to Buy According to Analysts? - Insider Monkey

Oct 20, 2024

Oct 18, 2024

Summit Therapeutics (NASDAQ:SMMT) Shares Up 0.5%Should You Buy? - MarketBeat

Oct 18, 2024